Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 201, Issue -, Pages 110733
Publisher
Elsevier BV
Online
2023-05-26
DOI
10.1016/j.diabres.2023.110733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
- (2023) Zobair M. Younossi et al. HEPATOLOGY
- Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis
- (2023) Song Lu et al. Journal of Translational Medicine
- Association between bedtime at night and nonalcoholic fatty liver disease diagnosed by liver ultrasound transient elastography
- (2022) Junfeng Zhou et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
- (2022) P. Barton Duell et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction–associated Fatty Liver Disease
- (2022) Hangkai Huang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of non-invasive biomarkers on hepatology practice: Past, present and future
- (2022) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- Breakthroughs in therapies for NASH and remaining challenges
- (2022) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
- (2022) Daniel Q. Huang et al. Cell Metabolism
- What is ‘remnant cholesterol’?
- (2022) Paulina E Stürzebecher et al. EUROPEAN HEART JOURNAL
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
- (2021) Renato Quispe et al. EUROPEAN HEART JOURNAL
- Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
- (2021) Mojgan Masoodi et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center
- (2021) Max Shen et al. Journal of Clinical and Translational Hepatology
- Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study
- (2021) Yang Zou et al. Lipids in Health and Disease
- Missense variant in insulin receptor (Y1355H) segregates in family with fatty liver disease
- (2021) Fei Luo et al. Molecular Metabolism
- Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
- (2021) Fei Luo et al. Cellular and Molecular Gastroenterology and Hepatology
- Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study
- (2020) Kushala W M Abeysekera et al. Lancet Gastroenterology & Hepatology
- Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey
- (2020) Stefano Ciardullo et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
- (2020) Jong Hwa Choi et al. Clinical and Molecular Hepatology
- Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease
- (2020) Olga Castañer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Vibration-controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
- (2018) Alessandro Mantovani et al. DIABETES CARE
- Science, serendipity, and the single degree
- (2018) Helen H. Hobbs JOURNAL OF CLINICAL INVESTIGATION
- Use of Liver Imaging and Biopsy in Clinical Practice
- (2017) Elliot B. Tapper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-alcoholic fatty liver disease and dyslipidemia: An update
- (2016) Niki Katsiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol
- (2013) F. Shojaee-Moradie et al. DIABETES
- The Spontaneous Course of Liver Enzymes and Its Correlation in Nonalcoholic Fatty Liver Disease
- (2012) Phunchai Charatcharoenwitthaya et al. DIGESTIVE DISEASES AND SCIENCES
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
- (2009) C. H. KIM et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
- (2009) Koji Fujita et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now